drugset
drugset / Trial / NCT05789186

Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents

NCT05789186 ↗

Phase 0 Unknown 108 enrolled Chen Qian
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized controlled trial was conducted to observe the improvement of mild to moderate depressive symptoms in children and adolescents with the aromatic herbal compound Cang Ai Volatile Oil (CAVO) and to evaluate the effectiveness and safety of the clinical application of CAVO.

Timeline

Start
2023-05-01
Primary completion
2023-09-01
Completion
2024-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cang Ai Volatile Oil Traditional medicine (herbal / TCM) 3 % Inhaled
Comparator Fluoxetine Small molecule 10 mg Oral

Indications

depressive disorder